Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...
Curious about how protein crystallography fits into modern drug discovery? In this on-demand webinar, Dr. Thomas Pesnot from Concept Life Sciences chats with Dr. Debanu Das of Accelero Biostructure, ...
Researchers unveil the first 48-channel high-throughput SPR platform, enabling primary screening of large molecular libraries with high-resolution binding data, 12-fold higher throughput, and minimal ...
Vega instrument combines ultra-high-throughput, data quality, and assay flexibility for both traditional and AI-based drug discoveryEnables ...
A team of UC Santa Barbara engineering and molecular biology graduate students has developed software to accelerate the discovery process for therapies ...
Pharmaceutical Technology on MSN
RNA-targeting small molecules: A new frontier of drug discovery
With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology ...
Sygnature Discovery, an integrated drug discovery contract research organization (CRO), reports that it completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory ...
Revvity offers comprehensive solutions designed to help accelerate laboratory workflows, assisting researchers meet targets faster and bring new therapies to market sooner. Our integrated approach ...
SYDNEY--(BUSINESS WIRE)--Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUM™ Allegro, a groundbreaking advancement in 3D cell culture technology ...
Drug discovery pipelines are notorious for being costly, slow, and failure-prone, leading to AI and machine learning becoming more commonplace to accelerate progress and improve outcomes. Currently, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results